戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 d several other salivary proteins, including secretory immunoglobulin A.
2 ame SpsA, the protein has been shown to bind secretory immunoglobulin A.
3 heart rate variability, salivary cortisol or secretory Immunoglobulin A.
4             Therefore, a complex enriched in secretory immunoglobulin A and alpha-amylase forms a S.
5 itivity skin reactions, and mucosal defense (secretory immunoglobulin A and dual-sugar permeability).
6 B subunits of cholera toxin induced specific secretory immunoglobulin A and serum immunoglobulin G an
7 c lymphocytes; reduced complement formation, secretory immunoglobulin A, and interferon; and lower T
8 re fecal glucocorticoid metabolite (FGM) and secretory immunoglobulin A concentrations.
9 osal secretions containing T. cruzi-specific secretory immunoglobulin A harvested from immune mice we
10       Intestinal M cells bear a receptor for secretory immunoglobulin A (IgA) (sIgA) facing the lumen
11        Fecal extracts were assayed for total secretory immunoglobulin A (IgA) and C. parvum-specific
12 ated significant levels of specific salivary secretory immunoglobulin A (IgA) and serum IgG antibodie
13                                              Secretory immunoglobulin A (IgA) and systemic IgG2a anti
14 immunity for optimal induction of protective secretory immunoglobulin A (IgA) and systemic type 1 imm
15 , respectively, were adherent to immobilized secretory immunoglobulin A (IgA) and two IgA1 myeloma pr
16 y subunit that were recognized by intestinal secretory immunoglobulin A (IgA) antibodies from immune
17 le mucosal immunity to ricin correlates with secretory immunoglobulin A (IgA) antibody levels in vivo
18 r with a mixture of these strains, developed secretory immunoglobulin A (IgA) in tears and serum IgG
19                                              Secretory immunoglobulin A (IgA) protects the mucosal su
20  and cholera holotoxin induced an intestinal secretory immunoglobulin A (IgA) response (P < 0.01 comp
21    Mice infected with C. rodentium develop a secretory immunoglobulin A (IgA) response, but the role
22 time without causing disease while eliciting secretory immunoglobulin A (IgA) responses, as evidenced
23 nterleukin-12 (IL-12) can stimulate elevated secretory immunoglobulin A (IgA) responses.
24 emonstrated significant roles of RV-specific secretory immunoglobulin A (IgA), CD4+ T cells, and CD8+
25 ation was studied using T helper 1 cytokines/secretory immunoglobulin A (IgA), histatins and lysozyme
26  permeability by affecting the production of secretory immunoglobulin A (IgA), the main immune mechan
27 g antibodies in sera and of peptide-specific secretory immunoglobulin A in nasal secretions.
28 zed by enzyme-linked immunosorbent assay for secretory immunoglobulin A, lactoferrin, lysozyme, and i
29 nduced significant increases in LAM-reactive secretory immunoglobulin A (P<.05).
30 ecessary for optimal induction of protective secretory immunoglobulin A responses.
31 rechallenge and, if so, whether antireovirus secretory immunoglobulin A (S-IgA) is a necessary compon
32                                      Mucosal secretory immunoglobulin A (s-IgA) is an antibody protei
33 use permitted inquiry into the regulation of secretory immunoglobulin A (S-IgA) responses by substanc
34 surface protein C (PspC) binds to both human secretory immunoglobulin A (sIgA) and complement factor
35                                              Secretory immunoglobulin A (SIgA) antibodies directed ag
36                                              Secretory immunoglobulin A (SIgA) antibodies reactive wi
37                                 In addition, secretory immunoglobulin A (sIgA) antibodies were detect
38 s with biochemical approaches to investigate secretory immunoglobulin A (SIgA) as a substrate of BV-a
39                             PspK bound human secretory immunoglobulin A (sIgA) but not the complement
40 s to explore the association between natural secretory immunoglobulin A (sIgA) capsular antibodies in
41 ject of this study was to determine if stool secretory immunoglobulin A (sIgA) concentrations in chil
42                                           As secretory immunoglobulin A (SIgA) deficiency in small ai
43                                              Secretory immunoglobulin A (SIgA) enhances host-microbio
44 otein and amino acids, fat, lactoferrin, and secretory immunoglobulin A (sIgA) in human milk of a sub
45 stinal permeability and elevated circulating secretory immunoglobulin A (sIgA) in KD patients, as wel
46                                              Secretory immunoglobulin A (SIgA) is the single most abu
47                                              Secretory immunoglobulin A (sIgA) plays an important rol
48 ites, the mucus, antimicrobial peptides, and secretory immunoglobulin A (sIgA) protect the intestinal
49                                              Secretory immunoglobulin A (sIgA) represents the immune
50 ents of HM: lysozyme (LZ), lactoferrin (LF), secretory immunoglobulin A (sIgA), basal lipase (BL), cy
51 ents of HM: lysozyme (LZ), lactoferrin (LF), secretory immunoglobulin A (sIgA), basal lipase (BL), cy
52      We investigated the role of whole human secretory immunoglobulin A (sIgA), M6 protein-specific s
53      Furthermore, it expresses receptors for secretory immunoglobulin A (SIgA), the main antibody in
54                         The binding of human secretory immunoglobulin A (SIgA), the primary immunoglo
55 eliac disease and promotes retrotransport of secretory immunoglobulin A (SIgA)-gliadin complexes.
56 st immunity pathway that involves intestinal secretory immunoglobulin A (sIgA).
57                       Meanwhile, heart rate, secretory immunoglobulin A, standing and lying all showe